SPRY News

Class Action Reminder from Pomerantz LLP for Shareholders of ARS Pharmaceuticals, Inc. – SPRY

SPRY UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026 Ready to Announce with Confidence?

Kaplan Fox Notifies Investors: Deadline to Lead in the ARS Pharmaceuticals Inc. (SPRY) Securities Class Action is October 5, 2026 Ready to Announce with Confidence?

Securities Fraud Class Action Filed Against ARS Pharmaceuticals, Inc. (SPRY) - Levi & Korsinsky Reminds Investors of October 5, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – SPRY

ARS PHARMACEUTICALS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 5 Deadline in Securities Class Action - SPRY

SPRY LAWSUIT ALERT: Levi & Korsinsky Notifies ARS Pharmaceuticals, Inc. Investors - Lead Plaintiff Deadline October 5, 2026

SPRY SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ARS Pharmaceuticals Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!

Top Los Angeles Spine Surgeon Dr. Albert Wong Served as Faculty Leader at Advanced Spine Surgery Cadaver Training Courses for SeaSpine and Globus

ARS Pharmaceuticals, Inc. (SPRY) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before October 5, 2026